Adenovirus HSV-TK construct with thyroid-specific promoter: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the camp pathway (Q43981141)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Adenovirus HSV-TK construct with thyroid-specific promoter: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the camp pathway	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Adenovirus HSV-TK construct with thyroid-specific promoter: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the camp pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

4

object named as

Tito Fojo

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Masaki Kitazono

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Yutaka Chuman

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Takashi Aikou

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

453-459

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Thyroid cancer: a lethal endocrine neoplasm

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Anaplastic carcinoma of the thyroid: A clinicopathologic study of 121 cases

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Anaplastic thyroid carcinoma: current diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

External radiotherapy in thyroid cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Progress in transcriptionally targeted and regulatable vectors for genetic therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Adenoviral infection of thyroid cells: a rationale for gene therapy for metastatic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

An unusually long poly(purine)-poly(pyrimidine) sequence is located upstream from the human thyroglobulin gene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Identification of a thyroid-specific and cAMP-responsive enhancer in the upstream sequences of the human thyroglobulin promoter

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Gene Therapy for Hemophilia B: Host Immunosuppression Prolongs the Therapeutic Effect of Adenovirus-Mediated Factor IX Expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Expression of HGF/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

In VivoTherapy of Hepatocellular Carcinoma with a Tumor-Specific Adenoviral Vector Expressing Interleukin-2

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Thyroid peroxidase gene promoter confers TSH responsiveness to heterologous reporter genes in transfection experiments

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination Adriamycin and radiation therapy. A new approach

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Anaplastic carcinoma of the thyroid: a 24-year experience

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Gap junctions: the "kiss of death" and the "kiss of life"

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10307

21 January 2018

Identifiers

10.1002/IJC.10307

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43981141&oldid=2105263410"